|2017||Anthony J. Gill|
|2015||Charles G. Mullighan|
|2014||A. John Iafrate|
|2013||Celina G. Kleer|
|2010||Jorge S. Reis-Filho|
|2007||Arul M. Chinnaiyan|
|2006||Kojo S. J. Elenitoba-Johnson|
|2004||Mark A. Rubin|
|2003||Julia A. Bridge|
|2002||Frederic G. Barr|
|1998||Cheryl L. Willman|
|1997||Christopher D. M. Fletcher|
|1996||James R. Downing|
Brigham & Women's Hospital and the United States and Canadian Academy of Pathology
The Ramzi S. Cotran Young Investigator Award was established by the USCAP Board of Directors to recognize a body of investigative work which has contributed significantly to the diagnosis and understanding of human disease. This award is restricted to USCAP members who are under the age of 45 and in good standing with USCAP for at least one year prior to receiving the award.
This important award is named after Dr. Ramzi S. Cotran, Past-President of USCAP, outstanding pathologist, person, and mentor.
The award consists of a commemorative plaque and $5,000.
- Application form, completed and signed by the applicant
- Curriculum Vitae (CV)
- Letter from a nominating sponsor (not necessarily a USCAP member) summarizing the nominee’s qualifications for the award
- Supporting letter from an additional sponsor who must be a member of USCAP
Awardees are selected by The Ramzi S. Cotran Young Investigator Award Committee. Committee members rank the candidates and provide their assessment to the Committee Chair. The Chair notifies the Executive Vice President (EVP) of his/her selection. The EVP presents the individual to the Board of Directors for ratification (preferably at the Interim Meeting) and subsequently notifies the winner and arranges for the plaque and check. The awardee does not have to be present at the Annual Meeting and travel funds are not included.
It is preferable that the Ramzi S. Cotran Professor (Harvard Medical School) and Chair, Department of Pathology, Brigham and Women’s Hospital, Dr. Jeffrey A. Golden, will present the award on March 20, 2018 at the annual meeting in Vancouver, Canada.
Note: The deadline for The Ramzi S. Cotran Young Investigator Award is Thursday, October 12, 2017.
Anthony J. Gill, MBBS, FRCPA, M.D.
Dr. Anthony Gill was born at Royal North Shore Hospital in Sydney in the old maternity unit, not more than 20 meters from the location of his current office and laboratory. He attended the Shore School on a full academic scholarship where he was dux and prefect before progressing to fulfilling his childhood dream to study medicine (MBBS) at the University of Sydney. He graduated with the Royal North Shore Hospital Medal and prizes for first in the university in both Medicine and Surgery in 1996. His postgraduate training included clinical years as an intern, resident and registrar in both internal medicine and emergency. Almost on a whim in 2000 he commenced training in the dark arts of Anatomical Pathology at Royal North Shore Hospital under the tutelage of pathologists whom he greatly respects including Judith Fryer, Jeanette Philips and Roberts Eckstein. He was immediately entranced by the ability of dedicated and highly trained pathologists to make critical decisions and directly and dramatically help patients on a daily basis, often despite minimal community recognition.
During his training he had the opportunity to learn at Royal Prince Alfred Hospital, the Children’s Hospital Westmead and the NSW Institute of Forensic Medicine. He qualified FRCPA in 2005 and commenced practice as a staff specialist at Royal North Shore Hospital with special interest in endocrine, gastrointestinal and pancreaticobiliary pathology. He also commenced translational research in surgical pathology gravitating towards the areas of endocrine and pancreaticobiliary pathology primarily because it was in these areas that he encountered particularly passionate and dedicated clinical and laboratory teams. He was awarded a higher doctorate by publication by the University of Sydney in 2011 and promoted to Associate Professor in 2012.
Seeing a strong need for pathologists to not just contribute to translational research in clinical fields and the basic sciences, but also to be given the opportunity to undertake pathologist directed research explicitly in the field of surgical pathology, he founded the Cancer Diagnosis and Pathology – website www.cancerdxpathology.org.au – with a mission to facilitate research by surgical pathologists in surgical pathology. He has published extensively both within the structure of this group and in major international collaborations including the International Cancer Genome Consortium (ICGC) where he was a key member of the Australian Pancreatic Genome Initiative, initially as lead pathologist and now as chairman. He was awarded a personal chair as Professor of Surgical Pathology at the University of Sydney in 2016.
Dr. Gill has co-authored more than 240 original research publications (more than one quarter as senior scientific author) but is particularly proud of his work in the field of succinate dehydrogenase deficient neoplasia. While he fully acknowledges the work of many other research groups in this very active field, his work has been crucial to the widespread recognition of both succinate dehydrogenase deficient GIST and succinate dehydrogenase deficient renal cell carcinoma as unique entities with profound clinical significance. He has been a co-author of 10 WHO ‘Blue Book’ chapters across three different books and was a member of the WHO Consensus Committee which met in Lyons, France (April 26–28 2016) to finalize the 4th Edition 2017 Genetics of Tumour of Endocrine Organs. He is grateful for the recognition that his work has achieved including the 2011 Benjamin Castleman Award from USCAP, the 2014 NSW Premier’s Award for excellence in Translational Cancer Research and the NSW Cancer Institute Wildfire Award (twice).
He is particularly grateful to his surgical pathology collaborators and mentors. He has always felt welcomed by the international community of pathologists from around the world and, in particular, by USCAP.